TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 40 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -34.0% | 176 | +8.0% | 0.00% | – |
| Q2 2023 | $47 | -88.9% | 163 | -27.2% | 0.00% | – |
| Q1 2023 | $423 | +31.0% | 224 | +3.2% | 0.00% | – |
| Q4 2022 | $323 | -67.7% | 217 | -76.2% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 910 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 910 | +1.6% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 896 | -32.6% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 1,330 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -91.2% | 1,330 | -84.8% | 0.00% | – |
| Q2 2021 | $57,000 | +35.7% | 8,759 | +74.4% | 0.00% | – |
| Q1 2021 | $42,000 | -51.2% | 5,022 | -31.5% | 0.00% | – |
| Q4 2020 | $86,000 | +514.3% | 7,329 | +166.1% | 0.00% | – |
| Q3 2020 | $14,000 | +366.7% | 2,754 | +53.2% | 0.00% | – |
| Q2 2020 | $3,000 | -82.4% | 1,798 | -82.1% | 0.00% | – |
| Q1 2020 | $17,000 | +183.3% | 10,062 | +275.9% | 0.00% | – |
| Q4 2019 | $6,000 | – | 2,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |